A detailed history of Goldman Sachs Group Inc transactions in Evotec Se stock. As of the latest transaction made, Goldman Sachs Group Inc holds 57,141 shares of EVO stock, worth $285,705. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,141
Previous 64,856 11.9%
Holding current value
$285,705
Previous $311,000 33.12%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.96 - $5.34 $22,836 - $41,198
-7,715 Reduced 11.9%
57,141 $208,000
Q2 2024

Aug 13, 2024

BUY
$4.07 - $7.87 $263,963 - $510,416
64,856 New
64,856 $311,000

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.77B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.